Literature DB >> 28707371

Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Maha Khaleel1, Mammen Puliyel1, Payal Shah1, John Sunwoo2, Roberta M Kato3, Patjanaporn Chalacheva2, Wanwara Thuptimdang2, Jon Detterich4, John C Wood2,4, Jennie Tsao5, Lonnie Zeltzer5, Richard Sposto1,6, Michael C K Khoo2, Thomas D Coates1.   

Abstract

The painful vaso-occlusive crises (VOC) that characterize sickle cell disease (SCD) progress over hours from the asymptomatic steady-state. SCD patients report that VOC can be triggered by stress, cold exposure, and, pain itself. We anticipated that pain could cause neural-mediated vasoconstriction, decreasing regional blood flow and promoting entrapment of sickle cells in the microvasculature. Therefore, we measured microvascular blood flow in the fingers of both hands using plethysmography and laser-Doppler flowmetry while applying a series of painful thermal stimuli on the right forearm in 23 SCD patients and 25 controls. Heat pain applied to one arm caused bilateral decrease in microvascular perfusion. The vasoconstriction response started before administration of the thermal pain stimulus in all subjects, suggesting that pain anticipation also causes significant vasoconstriction. The time delay between thermal pain application and global vasoconstriction ranged from 5 to 15.5 seconds and increased with age (P < .01). Although subjective measures, pain threshold and pain tolerance were not different between SCD subjects and controls, but the vaso-reactivity index characterizing the microvascular blood flow response to painful stimuli was significantly higher in SCD patients (P = .0028). This global vasoconstriction increases microvascular transit time, and may promote entrapment of sickle cells in the microvasculature, making vaso-occlusion more likely. The rapidity of the global vasoconstriction response indicates a neural origin that may play a part in the transition from steady-state to VOC, and may also contribute to the variability in VOC frequency observed in SCD patients.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28707371      PMCID: PMC5880319          DOI: 10.1002/ajh.24858

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  56 in total

Review 1.  Sickle cell disease and nitric oxide: a paradigm shift?

Authors:  A Kyle Mack; Gregory J Kato
Journal:  Int J Biochem Cell Biol       Date:  2006-02-17       Impact factor: 5.085

2.  Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.

Authors:  M Maier-Redelsperger; C T Noguchi; M de Montalembert; G P Rodgers; A N Schechter; A Gourbil; D Blanchard; J P Jais; R Ducrocq; J Y Peltier
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

3.  Microcirculatory adaptations in sickle cell anemia: reactive hyperemia response.

Authors:  G P Rodgers; A N Schechter; C T Noguchi; H G Klein; A W Nienhuis; R F Bonner
Journal:  Am J Physiol       Date:  1990-01

4.  Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.

Authors:  D Bachir; A Maurel; Y Beuzard; M Razavian; A Kraiem; J L Portos; F Galacteros
Journal:  Microvasc Res       Date:  1993-11       Impact factor: 3.514

5.  Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures.

Authors:  R Hoover; R Rubin; G Wise; R Warren
Journal:  Blood       Date:  1979-10       Impact factor: 22.113

6.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

Review 7.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

8.  Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment.

Authors:  R P Hebbel; J W Eaton; M H Steinberg; J G White
Journal:  Blood Cells       Date:  1982

9.  Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst.

Authors:  T C Hofstra; V K Kalra; H J Meiselman; T D Coates
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

10.  Peripheral arterial tonometry: a diagnostic method for detection of myocardial ischemia induced during mental stress tests: a pilot study.

Authors:  Daniel A Goor; Jacob Sheffy; Robert P Schnall; Alexander Arditti; Avraham Caspi; Edith E Bragdon; David S Sheps
Journal:  Clin Cardiol       Date:  2004-03       Impact factor: 2.882

View more
  15 in total

Review 1.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 2.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

Review 4.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

5.  Autonomically-mediated decrease in microvascular blood flow due to mental stress and pain in sickle cell disease: A target for neuromodulatory interventions.

Authors:  Sarah R Martin; Payal Shah; Christopher Denton; Lonnie K Zeltzer; Saranya Veluswamy; Michael C K Khoo; Thomas D Coates
Journal:  Complement Ther Med       Date:  2020-02-15       Impact factor: 2.446

6.  Aura and mental stress are associated with reports of pain in sickle cell disease-a pilot study using a mobile application.

Authors:  Juan Espinoza; Payal Shah; Saranya Veluswamy; Lonnie Zeltzer; Michael C K Khoo; Thomas D Coates; Jacquelyn Baskin
Journal:  Am J Hematol       Date:  2020-02-05       Impact factor: 10.047

Review 7.  Pain in sickle cell disease: current and potential translational therapies.

Authors:  Varun Sagi; Aditya Mittal; Huy Tran; Kalpna Gupta
Journal:  Transl Res       Date:  2021-03-09       Impact factor: 10.171

8.  A novel cross-correlation methodology for assessing biophysical responses associated with pain.

Authors:  John Sunwoo; Patjanaporn Chalacheva; Maha Khaleel; Payal Shah; Richard Sposto; Roberta M Kato; Jon Detterich; Lonnie K Zeltzer; John C Wood; Thomas D Coates; Michael Ck Khoo
Journal:  J Pain Res       Date:  2018-10-05       Impact factor: 3.133

9.  Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease.

Authors:  Saranya Veluswamy; Payal Shah; Maha Khaleel; Wanwara Thuptimdang; Patjanaporn Chalacheva; John Sunwoo; Christopher C Denton; Roberta Kato; Jon Detterich; John C Wood; Richard Sposto; Michael C K Khoo; Lonnie Zeltzer; Thomas D Coates
Journal:  Blood       Date:  2020-09-03       Impact factor: 25.476

10.  Nocturnal peripheral vasoconstriction predicts the frequency of severe acute pain episodes in children with sickle cell disease.

Authors:  Patjanaporn Chalacheva; Yunhua Ji; Carol L Rosen; Michael R DeBaun; Michael C K Khoo; Thomas D Coates
Journal:  Am J Hematol       Date:  2020-10-23       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.